% | $
Quotes you view appear here for quick access.

Dynavax Technologies Corporation Message Board

  • dvaxwb dvaxwb Oct 16, 2012 4:32 PM Flag

    The main overhang in question for the meeting November 15th

    The biggest question Dynavax will face on November 15th will be the Wegener's case from clinical trials. Dynavax has done all due dilligence with additional trials and data to properly address this issue with supporting data, analysts at William Blair and Cowen & Company both have reports that properly address that specific case in detail.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
16.28-0.01(-0.06%)Aug 30 4:00 PMEDT